
Cooper Companies (COO) Stock Forecast & Price Target
Cooper Companies (COO) Analyst Ratings
Bulls say
Cooper Companies is well positioned in both the contact lens and reproductive healthcare markets, with a strong portfolio of products and a strong market presence. The potential launch of Sebela's LevoCept could provide further growth opportunities for Cooper in the future. Additionally, the company's recent strategic review and potential separation of its two segments could unlock further value for shareholders. However, there are potential risks to consider, such as increasing competition and currency headwinds, which could impact the company's growth and profitability. Overall, the company's strong fundamentals and potential growth opportunities make it a favorable investment choice.
Bears say
Cooper Companies is a leading medical device company with a strong presence in the contact lens and reproductive care markets. However, risks such as increasing competition, consumer weakness, and currency headwinds could negatively impact the company's performance. Our bear case scenario also suggests low-single digit growth and flat margins, leading to concerns about the company's future financial performance. Therefore, we have a negative outlook on Cooper Companies' stock, as we believe there are risks that could hinder the company's organic revenue growth and EPS growth potential in the future.
This aggregate rating is based on analysts' research of Cooper Companies and is not a guaranteed prediction by Public.com or investment advice.
Cooper Companies (COO) Analyst Forecast & Price Prediction
Start investing in Cooper Companies (COO)
Order type
Buy in
Order amount
Est. shares
0 shares